The effect of protein deprivation on plasma concentration of insulin-like growth factor-binding proteins (IGFBP) was studied in rats. A significant decrease in the concentration of IGFBP of molecular weight (mass) approximately 40 kDa was observed in protein-deprived rats. There was no prominent effect of protein deprivation on the concentration of IGFBP with molecular weights of about 30 kDa or 22-24 kDa. The binding capacity to plasma IGFBP of exogenously-added '2sI-labelled insulin-like growth factor-1 (l*sI-IGF-l) was also studied. IGFBP of molecular weight about 30 and 22-24 kDa (the native form of this protein is presumed to be 29 kDa) in protein-deprived rat plasma bound more 12sI-IGF-1 than those in protein-fed rat plasma. This suggested that these IGFBP in protein-deprived rat plasma are relatively unsaturated by endogenous IGF-1. The response of IGFBP to protein deprivation which was elucidated in the present investigations add further evidence to our previous assumption that IGFBP play an important role in protein nutrition.
Insulin-like growth factor-1 (IGF-1) is a protein, the concentration of which is largely affected by growth hormone and nutritional status of man and animals (for review, see Van Wyk, 1984; Froesch et al. 1985; LeRoith & Raizada, 1989) . In a previous paper, we demonstrated that the plasma concentration of IGF-1 is regulated by the quantity and nutritional quality of dietary proteins (Takahashi et a/. 1990 ).
This hormone has been shown to circulate in blood in forms conjugated with several kinds of proteins known as IGF-binding proteins (IGFBP) (Cohen & Nissley, 1975; Hintz & Liu, 1977) . At least three groups or species of IGFBP have been demonstrated in human or rat plasma (Kaufmann et al. 1977 (Kaufmann et al. , 1978 Binoux et al. 1982) (Fig. 4 explains the species of IGFBP). The first involves a complex of the molecular weight (mass) 150 kDa. This IGFBP can be chemically dissociated into two components which have been named as acidlabile subunit (ALS) and acid-stable subunit (ASS) (Furlanetto, 1980; Martin & Baxter, 1985; Wilkins & D'Ercole, 1985; Baxter, 1988) . I G F is bound to ASS. ASS is a glycoprotein of molecular weight approximately 53 kDa (Martin & Baxter, 1986) . However, sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE) gives a smaller molecular weight component, i.e. about 40 kDa (Rechler et al. 1 9 8 9~) . This subunit has been recently named IGFBP-3 (Ballard et al. 1989) . The second IGFBP has a molecular weight of approximately 30 kDa. This protein has been purified from amniotic fluid (Drop et af. 1984; Povoa et ul. 1984; Busby et a/. 1988a ) and the recent nomenclature is IGFBP-1 (Ballard ef a/. 1989). The third is that with a molecular weight approximately 22-24 kDa . However, this protein may exist as a glycoprotein of molecular weight a little smaller (approximately 29 kDa) than IGFBP-I, and may be converted to the 22-24 kDa molecule by the action of N-glycanase (Rechler et al. 1989a, b ; Yang et al. 1989) . These authors suggested that this 29 kDa protein is a N-terminal29 kDa fragment of IGFBP-3.
In human plasma, IGF-1 is primarily found to be conjugated with IGFBP-3 and shows an apparent molecular weight of 150 kDa (Moses et al. 1979; Hardouin et al. 1987) . The plasma concentration of this IGFBP has been shown to be affected largely by growth hormone (Moses et al. 1976; White et al. 1981 ; Grant et al. 1986) . The physiological significance of other IGFBP is controversial (Knauer & Smith, 1980; Cornell et al. 1987; Elgin et al. 1987; DeMellow & Baxter, 1988; Ritvos et al. 1988; Busby et al. 1989) .
In the previous paper (Takahashi et al. 1990) , we demonstrated that IGF-1 is found in rat plasma in two forms, i.e. one associated with a protein of molecular weight 150 kDa, and another with that of 40 kDa or smaller. The total and relative amounts of IGF-1 bound to each protein were affected by dietary protein source. Furthermore, there was a large difference between the dietary groups in the capacity of plasma fractions to bind exogenously-added '251-labelled IGF-1 ('"I-IGF-1). The explanation of these was based on the extent of saturation of IGFBP with endogenous IGF-1.
In the previous experiments, we employed a method of gel filtration for separation of IGFBP. That method could not differentiate all the molecular species of IGFBP. A recently-introduced method which separates IGFBP on sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE) makes it possible to differentiate the small differences among IGFBP (Hossenlopp et al. 1986; Hardouin et al. 1987) . In the present investigations, SDS-PAGE was used and the previous studies on the effect of protein status on plasma IGFBP in rats extended.
M A T E R I A L S A N D M E T H O D S

Animals and diets
Male Wistar rats were obtained from Japan SLC company (Shizuoka, Japan) and used throughout the experiments. The body-weight was approximately 100 g. The protein-free and casein (120 g/kg diet) diets were prepared as described previously (Takahashi et al. 1990 ). Rats were fed on these diets and water ad lib. for I week. At 11.30 hours on the 8th day they were anaesthetised with Nembutal, and blood samples were taken from the carotid artery. Materials IGF-1 was purchased from Boehringer Mannheim-Yamanouchi (Japan), and bovine serum albumin (BSA) from Sigma. Nylon membrane (GeneScreen Hybridization Transfer Membrane) was from NEN Research Products, Boston, MA, USA. Nalz5I (3.7 x lo9 Bq/ml) was obtained from Amersham (Japan Radioisotope Association). A molecular marker kit for SDS-PAGE was obtained from BioRad. Other chemicals were of the purest grade available commercially.
Determination of immunoreactive IGF-1 concentration and that after extraction with acid-ethanol (or total immunoreactive IGF-I concentration)
The methods were the same as described previously (Takahashi et al. 1990 ).
Iodination of IGF-1 with '"I
The method was similar to that reported previously (Takahashi et al. 1990) . Briefly, 10 pl Nalz5I (37 MBq) and 10 pl chloramine T solution (1 mg dissolved in 1 ml 0.2 M-phosphate buffer, pH 7.4) were added to 10 p1 IGF-1 solution (recombinant human IGF-1, 1 pg/lO ,MI water). The mixture was mixed well and kept at room temperature for 60 s. Then sodium metabisulphite solution (2.5 mg sodium metabisulphite dissolved in 1 mlO.05 M-phosphate buffer, pH 7.5) was added in order to stop the reaction. From this mixture, the labelled IGF-1 was extracted three times with 100, 50 and 50 pl of transfer solution (1 litre of the solution contained 10 g potassium iodide, 80 g sucrose and 1 g Triton X-100 in distilled water). The extract was subjected to gel-filtration on a plastic column packed with Sephadex G-25M (bed volume 9 ml, 50 mm height ; Pharmacia) previously equilibrated with phosphate-buffered saline solution (0.14 M-sodium chloride-0.01 M-sodium phosphate, pH 7.5) containing 10 g BSA/l. The labelled IGF-I was eluted with the same phosphatebuffered saline solution. Two peaks with radioactivity were eluted. The first peak was labelled IGF-1. The preparation was stored at -20". Just before use, this stored preparation was purified further by gel-filtration using an acryl column (1 5 mm diameter and 500 mm height) packed with Sephacryl S-200. The labelled IGF-1 was eluted with a solution containing 0.1 5 M-sodium chloride, 0.01 M-Tris-hydrochloric acid, 10 g BSA/l and 0.5 g sodium azide/l. Three radioactive peaks were obtained ; i.e. the peak associated with BSA, free IGF-1 and inorganic lZ51-. The second peak was used as the lZ5I-IGF-l preparation.
Analysis of IGFBP by Western ligand blotting
The method of Hossenlopp et al. (1986) and Hardouin et al. (1987) was employed. Briefly, 40pl plasma was mixed with an equal volume of SDS solution (1 litre of the solution contained 100 g /3-mercaptoethanol, 200 g glycerol, 50 g SDS, 20 mmol Tris and 2 mmol EDTA, pH 6.8) and incubated for 15 min at 60". A portion (40 pl) of the mixture was used for SDS-PAGE. The gel was 135 x 135 mm and 2 mm thick with 125 g polyacrylamide/l. The polyacrylamide gel was prepared according to Laemmli (1970) . The electrophoresis was performed at 180 V. After electrophoresis, proteins were transblotted to nylon membrane. After blotting, the membrane was incubated for 30 min at 4" in 30 g NP40/1 saline solution (0.15 M-N~CI, 0.01 M-Tris-HC1, 0.5 g sodium azide/l). Then the membrane was again incubated in 10 g BSA/1 in the saline solution for 6 h at 4". By these incubation procedures, non-specific binding of labelled IGF-1 was minimised. The membrane was incubated further in 1 g Tween 20/1 saline for 10 min at 4" in order to remove BSA. The membrane was then incubated with 1.8 ml lZ51-IGF-l solution (2-3 x lo6 counts/min (cpm)) for 10 h at 4" and then washed twice with the Tween 20 solution (each washing was for 15 min at 4"). The radioactivity which was bound to IGFBP was detected by autoradiography. After autoradiography, the portion with radioactivity on the filter was cut out and the radioactivity was determined with a gamma-counter (Aloka Auto Well Gamma System ARC-500).
Cross linking of '"I-IGF-1 with IGFBP
In order to determine the amount of IGFBP not associated with endogenous IGF-I, the following procedure ) was used.
Purified lZ5I-IGF-l (10 pl, approximately 50000 cpm, the amount was not exactly estimated but was more than that to saturate the vacant IGFBP) was mixed with 2Opl plasma and the mixture was incubated for 16 h at 4". Then 10 pl disuccimydyl suberate (DSS) solution (10 mg DSS/ml dimethylsulphoxide-water mixture (80: 20, v/v)) was added and the mixture was incubated for 15 min at 4". By this incubation, '251-IGF-l was covalently bound to IGFBP which had not been saturated with endogenous IGF-1. To this mixture, 40 p1 SDS solution was added and incubated for 15 min at 60". A 40 pl portion of the solution was used for SDS-PAGE. Electrophoresis conditions were as described previously except the gel was 1 mm thick. After electrophoresis, the gel was dried by a geldryer and the radioactivity in the dried gel was detected by autoradiography. The results of autoradiography were analysed using a densitometer (Computing densitometer ACD-18; ATTO, Tokyo, Japan). This method may make it possible to determine the amount of IGFBP not saturated with endogenous (unlabelled) IGF-1. However, other possibilities cannot be excluded (see p. 113).
Statistical analysis
The results were analysed statistically by one way classifications (analysis of variance, Snedecor & Cochran, 1967) . Table 1 shows the body weight changes and plasma immunoreactive IGF-1 or total IGF-1 concentration in the rats fed on the casein or protein-free diet. The results confirm our previous observations (Takahashi et af. 1990) . Fig. 1 shows the results of autoradiography after Western ligand blotting. Four radioactive bands were observed, i.e. two bands at about 40 kDa, one at about 30 kDa and one at about 22 kDa. The two bands found in the area of 40 kDa were found in the A fraction of the earlier gel filtration (Fig. 2) . These two bands probably are the same protein but glycosylated to different extents (Rechler et al. 1989a, b ; Yang et al. 1989) . The bands at about 30 kDa and about 22 kDa were in the C fraction obtained earlier. In Fig. 2 , 30 kDa IGFBP showed two bands (the larger one will be referred to as 30 kDa IGFBP and smaller one as 29 kDa IGFBP). The amount of 22 kDa band was very small. Therefore, we concluded that the two bands at about 40 kDa ( Fig. 1) were derived from the large binding protein (Takahashi et al. 1990 ) and bands at about 30 and 22 kDa were derived from the small binding protein. Tentatively, we refer to the two bands at 40 kDa as IGFBP-3, and the band at 30 kDa as IGFBP-I. From the assumption described on p. 113, 29 kDa IGFBP is tentatively presumed to be undegraded or native 29 kDa IGFBP and 22 kDa IGFBP as degraded 29 kDa IGFBP. Rechler et al. (1989a, b) and Yang et al. (1989) suggested that this protein is the N-terminal fragment of IGFBP-3. Table 2 shows the results of the determination of radioactivity found in the fractions of Fig. 1 . These results were obtained by counting the radioactivity after dissecting the bands. The total radioactivity of the bands at about 40 kDa decreased significantly after protein deprivation. Fig. 3 shows the results of cross-linking experiments. Three bands, one at 150 kDa and two bands at about 35 and 33 kDa, were found in protein-deprived rats and two additional bands, one at about 25 kDa and another at about 20 kDa in casein-fed animals. The dense bands at the bottom of the figure show the unbound 1'51-IGF-I which is comparable to peak D reported in the previous paper (Takahashi et al. 1990 , Fig. 2 ). This confirms that an excess amount of labelled IGF-1 for saturation of vacant IGFBP was used in the experiments. The molecular weight of IGF-1 cross-linked to IGFBP must be apparently larger than the binding protein not associated with IGF-1 by the molecular weight of IGF-1, 7 kDa. Besides, the acid-labile subunit, the molecular weight of which has been reported to be about 90-110 kDa , and acid-stable subunit, i.e. 40 kDa binding protein (Furlanetto, 1980; Martin & Baxter, 1985 Baxter, 1988) , are assumed to be non-covalently bound to each other in native condition. This complex is dissociated into subunits during SDS-PAGE. However, if plasma is treated with DSS, covalent bonds between ASS, ALS and IGF-1 are presumed to be formed and this complex Rat plasma was subjected to SDS-PAGE. After electrophoresis, proteins were transferred to nylon membrane. The proteins which bound '251-labelled-IGF-l were detected by autoradiography. Rats were fed on protein-free or casein (120 g/kg diet) diets (for details of dietary regimen, see p. 106).
R E S U L T S
is probably found at 150 kDa. The band at about 35 kDa is presumed to be 30 kDa IGFBP (IGFBP-I) ( Fig. 1) with bound radioactive IGF-1. The difference from the expected molecular weight (if 30 kDa IGFBP binds IGF-1, the molecular weight must be 37 kDa) is probably due to the three-dimensional conformation of the complex Rosenfeld et af. 1989) . The band at about 33 kDa may be 22 kDa IGFBP in Fig. 1 . However, 22 kDa IGFBP is presumably produced during incubation with SDS (for discussion, see p. 113) and the native form of the proteins may be 29 kDa IGFBP in Fig.  2 . If plasma is treated with DSS before treatment with SDS, conversion of 29 kDa IGFBP to 22 kDa is presumed to be inhibited. Therefore, undegraded 29 kDa IGFBP is found at the position of 33 kDa. We assume that the small difference in expected v. observed molecular weight (a 29 kDa IGFBP plus IGF-I should give 36 kDa complex) in this case is also due to the conformation of the complex. The proteins which appear as the bands at about 25 and 20 kDa after conjugation with "'I-IGF-l were not detected by Western ligand blotting. These proteins may be sensitive to SDS-PAGE and lose the ability to bind (Hossenlopp et al. 1986; Hardouin et al. 1987) . Rat plasma was subjected to Sephacryl S-200 gel filtration. The pooled fractions were used as the samples for SDS-PAGE. After SDS-PAGE, insulin-like growth factor-binding proteins were detected by Western ligand blotting (see Fig. 1 IGF-1 after SDS-PAGE. The origin of these proteins will also be discussed later. Figure  4 explains the relationship of the bands among Figs. 1, 2 and 3. Table 3 shows the results of densitometry of Fig. 3 . The results are expressed as the relative density of the bands and are not absolute values. The bands of about 35 and 33 kDa (IGFBP-I and 29 kDa IGFBP conjugated with lZ5I-IGF-1) increased significantly in protein-deprived rats. This is presumed to be the increase in unsaturated IGFBP, because PROTEIN DEPRIVATION A N D I G F -B I N D I N G PROTEIN For details of dietary regimen, see p. 106.
1
Protein free Casein Fig. 3 . Sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE) of the insulin-like growth factor-binding proteins covalently bound with labelled IGF-1. 1Z51-labelled IGF-1 was covalently bound to IGFbinding proteins in rat plasma which had the capacity to bind exogenously added IGF-1. Then the plasma proteins were subjected to SDS-PAGE. The labelled proteins were detected by autoradiography. Rats were fed on proteinfree or casein diets (for details of dietary regimen, see p. 106).
the total amount of these IGFBP did not change significantly (Table 2 ). These observations are consistent with the former observation that the small BP in protein-deprived rats binds a larger amount of labelled IGF-1 than that in protein-fed rats (Takahashi et al. 1990 ). On the contrary, the bands at 150 kDa, 25 kDa or 20 kDa increased in casein-fed rats (Fig. 3) . The increase in radioactivity at 150 kDa is probably due to the increase in unsaturated 150 kDa IGFBP, because the total amount of its subunit, i.e., 40 kDa IGFBP in Fig. 1 , increased significantly. The reason for the increase in the 25 and 20 kDa bands, i.e. whether this is due to the increase in either unsaturated BP or in the total amount of the BP, cannot be explained at present because these proteins were not observed in Western blotting experiments.
D I S C U S S I O N
Firstly, let us consider the molecular species of IGFBP in rat plasma. At present, we agree with the discussion of Rechler et al. (1989a, b) and Yang et al. (1989) and explain our results as follows. By SDS-PAGE, four IGFBP bands are detected. The two at about 40 kDa are IGFBP-3; these two bands are the same protein with different sugar contents. The band at 30 kDa is IGFBP-1. The band at 22 kDa was produced from 29 kDa IGFBP during incubation with SDS at 60°, probably by the endogenous glycosidase (or, less likely, by endogenous protease). Thus, if plasma is gel-filtrated before SDS-PAGE (Fig. 2) , only a little 22 kDa protein is produced. The endogenous enzyme(s) must be contained in fractions other than those with 29 kDa protein (probably fraction A). Furthermore, if the original plasma is treated with DSS before SDS-PAGE, 22 kDa protein is not produced because DSS denatures the endogenous enzyme(s) or 29 kDa IGFBP cross-linked to IGF-1 is resistant to the endogenous enzyme(s). The 29 kDa IGFBP may be the N-terminal fragment of IGFBP-3 as suggested by Rechler et al. (1989a, b) and Yang et al. (1989) . We presume that 29 kDa IGFBP exists in native plasma not bound with ALS (if 29 kDa IGFBP is found in plasma non-covalently bound with ALS, the complex will be recovered in the fraction A of Fig. 2 ), because this IGFBP was found in the experiments shown in Figs. 2 and 3. These hypotheses are summarized in Fig. 4 .
The present investigations extend the earlier observations and elucidate the mechanisms involved (Takahashi et al. 1990 ). The results show that the total amount of IGFBP and the amount of IGF-1-saturated binding proteins are affected greatly by the status of protein nutrition. As shown in the present paper, the amount of large binding protein or 150 kDa IGFBP containing the 40 kDa subunit, IGFBP-3, decreases greatly with protein deprivation. Although the total amount of small binding protein, which is composed of at least two components, did not change significantly, the saturability of the binding protein was affected greatly by protein deprivation. Even if 29 kDa IGFBP is a N-terminal fragment of IGFBP-3, it is probably not an artifact produced during plasma handling, because the response of this protein to nutritional status of the animals was clearly different from that of IGFBP-3 (Tables 1 and 2) .
From these results and the previous observations, we conclude the effect of protein deprivation on IGF-I and IGFBP is as follows. When rats are deprived of dietary protein, the amount of large binding protein decreases concomitant with a decrease in IGF-1 associated with this protein. At the same time, the amount of IGF-1 bound to small binding proteins decreases because the total amount of IGF-1 in plasma decreases. The total amount of small binding protein is not affected significantly but the saturability of small binding protein decreases significantly.
There is no clear explanation at present on the physiological role of different kinds or groups of binding proteins (Cornell et al. 1987) . The 150 kDa IGFBP, which is composed of two subunits (Furlanetto, 1980; Martin & Baxter, 1985; Baxter, 1988) , has been assumed to be IGF-I reservoir protein in humans (Busby et al. 1 9 8 8~; Blum et al. 1989 ) because almost all IGF-I is found associated with this protein in plasma (Moses et al. 1979) . The amount of this protein is presumably regulated by the amount of acid-stable subunit (40 kDa) or IGFBP-3 because relatively larger amounts of acid-labile subunit are assumed to be produced (Furlanetto, 1980; Martin & Baxter, 1985; Baxter, 1988) . However, there is no clear information concerning the tissue which produces this protein or its subunits. Fibroblasts, osteoblasts or vascular epithelial or endothelial cells have been suggested as sources (Binoux et al. 1981 ; Rutanen et al. 1985 Rutanen et al. , 1986 Koistinen et al. 1986; Bar et al. 1989; Schrnid, et al. 1989) . Very recently, IGFBP-3 mRNA was demonstrated in rat liver by Northern blot analysis (Albiston & Herington, 1990) . Before final conclusions can be drawn, detection of mRNA (or other technical approaches) of the subunits in various tissues will be required (Brewer et al. 1988; Lee et al. 1988; Brown et al. 1989) .
The role of small binding proteins is not known either. Although the total amount of these proteins was not affected significantly by protein deprivation, the amount has been shown to increase during fasting (Rechler et al. 1989b ) and change diurnally (Baxter & Cowell, 1987; Busby et al. 1988b) . It reaches maximum concentration before a meal. This diurnal rhythm will not affect the present results, because we took all the blood samples at around 11.30 hours in the morning. There is a discrepancy concerning the effect of these small binding proteins on the biological activity of IGF-1. Some experiments suggest that the binding proteins suppress the activity of IGF-I (Knauer & Smith, 1980; Ritvos et al. 1988) and others that they enhance the activity (Elgin et al. 1987; Busby et al. 1989) . It is possible that the binding proteins enhance the IGF-1 activity in some tissues and depress it in others (DeMellow & Baxter, 1988) .
The origin of binding proteins in 22 kDa and 15 kDa fractions (Fig. 3) is not known yet. Baxter and his coworkers showed that the subunit of 150 kDa binding protein, i.e. IGF-BP-3, is easily dissociated to small fractions which still have a capacity to bind IGF-1 (Martin & Baxter, 1985; Baxter, 1988) . The two small binding proteins may be the product of IGFBP-3. However, further studies are required to prove this. It is also possible that one or more of these binding proteins is the IGF-I inhibitor reported by Herington and others (Herington & Kuffer, 1981; Ooi & Herington, 1986 , 1988 Wang et al. 1988) .
The present results clearly showed that the amount of IGFBP, and possibly their saturability, is largely affected by the status of protein nutrition. IGF-1 has been suggested to play important roles in protein anabolism. If IGFBP affect the activity of IGF-1 as suggested by many investigators, elucidation of the changes in IGFBP under various nutritional conditions will be very important in the assessment of the status of protein nutrition of man, particularly in protein-deprived children or patients losing body protein because of various diseases.
